Authors: SungKeum Seo HyungChahn Lee SangHyeok Woo HyeonOk Jin DooHyun Yoo SuJae Lee Sungkwan An TaeBoo Choe MyungJin Park SeokIl Hong InChul Park ChangHun Rhee
Publish Date: 2006/11/21
Volume: 12, Issue: 1, Pages: 195-
Abstract
Nonsteroidal antiinflammatory drugs are well known to induce apoptosis of cancer cells independent of their ability to inhibit cyclooxygenase2 but the molecular mechanism for this effect has not yet been fully elucidated The purpose of this study was to elucidate the potential signaling components underlying sulindacinduced apoptosis in human multiple myeloma MM cells We found that sulindac induces apoptosis by promoting ROS generation accompanied by opening of mitochondrial permeability transition pores release of cytochrome c and apoptosis inducing factor from mitochondria followed by caspase activation Bcl2 cleavage and downregulation of the inhibitor of apoptosis proteins IAPs family including cIAP1/2 XIAP and survivin occurred downstream of ROS production during sulindacinduced apoptosis Forced expression of survivin and Bcl2 blocked sulindacinduced apoptosis Most importantly sulindacderived ROS activated p38 mitogenactivated protein kinase and p53 SB203580 a p38 mitogenactivated protein kinase inhibitor and RNA inhibition of p53 inhibited the sulindacinduced apoptosis Furthermore p53 Bax and Bak accumulated in mitochondria during sulindacinduced apoptosis All of these events were significantly suppressed by SB203580 Our results demonstrate a novel mechanism of sulindacinduced apoptosis in human MM cells namely accumulation of p53 Bax and Bak in mitochondria mediated by p38 MAPK activation downstream of ROS production
Keywords: